Literature DB >> 28336180

An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT).

Ling Xiao1, Guoyu Pan2.   

Abstract

The enterohepatic circulation of bile acids (BAs) is governed by specific transporters expressed in the liver and the intestine and plays a critical role in the digestion of fats and oils. During this process, the majority of the BAs secreted from the liver is reabsorbed in intestinal epithelial cells via the apical sodium-dependent bile acid transporter (ASBT/SLC10A2) and then transported into the portal vein. Previous studies revealed that regulation of the ASBT involves BAs and cholesterol. In addition, abnormal ASBT expression and function might lead to some diseases associated with disorders in the enterohepatic circulation of BAs and cholesterol homeostasis, such as diarrhoea and gallstones. However, decreasing cholesterol or BAs by partly inhibiting ASBT-mediated transport might be used for treatments of hypercholesterolemia, cholestasis and diabetes. This review mainly discusses the regulation of the ASBT by BAs and cholesterol and its relevance to diseases and treatment.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28336180     DOI: 10.1016/j.clinre.2017.02.001

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  19 in total

1.  Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model.

Authors:  Linghua Yu; Linlin Wang; Huixing Yi; Xiaojun Wu
Journal:  Gut Microbes       Date:  2020-03-13

2.  Efficient SNP editing in haploid human pluripotent stem cells.

Authors:  Lauren Zakarin Safier; Michael V Zuccaro; Dietrich Egli
Journal:  J Assist Reprod Genet       Date:  2020-03-11       Impact factor: 3.412

Review 3.  Emerging roles of bile acids in mucosal immunity and inflammation.

Authors:  Mei Lan Chen; Kiyoshi Takeda; Mark S Sundrud
Journal:  Mucosal Immunol       Date:  2019-04-05       Impact factor: 7.313

4.  Selenocoxib-3, a novel anti-inflammatory therapeutic effectively resolves colitis.

Authors:  Ramanpreet Kaur; Dhimant Desai; Shantu Amin; Kaisar Raza; Aman Bhalla; Pooja Yadav; Naveen Kaushal
Journal:  Mol Cell Biochem       Date:  2022-08-24       Impact factor: 3.842

5.  SLC10A7, an orphan member of the SLC10 family involved in congenital disorders of glycosylation.

Authors:  Valérie Cormier-Daire; François Foulquier; Zoé Durin; Johanne Dubail; Aurore Layotte; Dominique Legrand
Journal:  Hum Genet       Date:  2022-01-08       Impact factor: 5.881

6.  A comparative analysis of the intrauterine transcriptome in fertile and subfertile mares using cytobrush sampling.

Authors:  Stefan Bauersachs; Heinrich Bollwein; Katharina S Weber; Karen Wagener; Miguel Blanco
Journal:  BMC Genomics       Date:  2021-05-22       Impact factor: 3.969

Review 7.  A Link between Intrahepatic Cholestasis and Genetic Variations in Intracellular Trafficking Regulators.

Authors:  Qinghong Li; Yue Sun; Sven C D van IJzendoorn
Journal:  Biology (Basel)       Date:  2021-02-04

8.  A Combination of Lactoplantibacillus plantarum Strains CECT7527, CECT7528, and CECT7529 Plus Monacolin K Reduces Blood Cholesterol: Results from a Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Rafael Guerrero-Bonmatty; Guadalupe Gil-Fernández; Francisco José Rodríguez-Velasco; Jordi Espadaler-Mazo
Journal:  Nutrients       Date:  2021-04-06       Impact factor: 5.717

9.  Total flavonoids of Astragalus Ameliorated Bile Acid Metabolism Dysfunction in Diabetes Mellitus.

Authors:  Zhe Wang; Xu-Ling Li; Kin-Fong Hong; Ting-Ting Zhao; Rui-Xue Dong; Wei-Ming Wang; Yun-Tong Li; Gui-Lin Zhang; Jing Lin; Ding-Kun Gui; You-Hua Xu
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-12       Impact factor: 2.629

10.  Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency.

Authors:  Ying Li; Dandan Yang; Yian Wang; Zhan Li; Chunyan Zhu
Journal:  Int J Nanomedicine       Date:  2018-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.